Home / Ampicillin and Beta-Lactamase Inhibitor / Germany
DE ATC J01CR01 · updated 2 Nov 2026
Ampicillin and Beta-Lactamase Inhibitor shortage in Germany
Is there an Ampicillin and Beta-Lactamase Inhibitor shortage in Germany?
Yes. As of 2 Nov 2026, 1 Ampicillin and Beta-Lactamase Inhibitor product is reported short in Germany, the first since 1 Jun 2026. The company estimate for the return is 31 Mar 2028. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Ampicillin/Sulbactam PUREN 2000 mg/1000 mg Pulver zur Herstellung einer Infusionslösung | Eugia Pharma (Malta) Limited | 1 Jun 2026 | 31 Mar 2028 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.